Ultrasound and Respiratory Physiological Signals in Lung Diseases
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Sep 28, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how ultrasound technology can help evaluate lung diseases, specifically looking at conditions like interstitial lung disease, chronic obstructive pulmonary disease (COPD), and other related lung issues. Researchers want to better understand how ultrasound images can show changes in the lungs, especially in areas that are still filled with air, and how certain patterns in these images can indicate health problems.
To participate in the trial, you need to be an inpatient with a serious lung condition that is currently worsening or an outpatient with stable emphysema or COPD. You should also be able to provide your written consent to join. Participants will undergo ultrasound examinations, and while this procedure is non-invasive and generally safe, it’s important to note that individuals with certain skin allergies, severe skin conditions, or other specific medical devices may not be eligible. Overall, the trial aims to improve our understanding of lung health and how ultrasound can be used as a valuable tool in diagnosing lung diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • inpatients admitted to the hospital due to diffuse interstitial lung diseases during exacerbation OR infectious interstitial pneumonia not caused by SARS-CoV-2 OR acute exacerbation of chronic obstructive pulmonary disease.
- • Outpatients with pulmonary paraseptal and/or panlobular emphysema and/or chronic obstructive pulmonary disease during stable phase.
- • Patients able to give written informed consent.
- Exclusion Criteria:
- • history of skin irritation, redness, itching or allergic cutaneous symptoms.
- • Allergic reactions to adhesives or hydrogels.
- • Family history of adhesive skin allergies.
- • Presence of severe skin conditions such as wounds, burns or on any damaged skin.
- • Presence of strong magnetic fields in the study setting.
- • Presence of electromagnetic disturbances or significant ionizing radiation sources which might lead to signal artifacts.
- • Use of external cardiac defibrillators.
- • Use of diaphragmatic pacers.
- • Use of extra cardiac stimulators.
- • Pregnancy.
- • Pediatric population.
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Trial Officials
Riccardo Inchingolo, MD, PhD
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Andrea Smargiassi, MD, PhD
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported